Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026)
Enanta Pharmaceuticals (ENTA) reported Prepaid Assets of $6.8 million for Q1 2026, down 23.11% on a YoY basis from $8.9 million in Q1 2025, and up 56.84% quarter-over-quarter from $4.3 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals has reported Prepaid Assets for 15 years, with the latest figure at $6.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 23.11% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (down 23.11% YoY), and the FY2025 full-year result was $8.6 million, down 30.8% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.8 million, up from $4.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $17.9 million in Q4 2022, with the low at $4.3 million in Q4 2025.
- Historically, Prepaid Assets has averaged $12.0 million across 5 years, with a median of $12.4 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 55.97% — and 2025, when it plunged 59.36%.
- Enanta Pharmaceuticals' Prepaid Assets stood at $17.9 million in 2022, then dropped by 26.2% to $13.2 million in 2023, then dropped by 19.34% to $10.7 million in 2024, then slumped by 59.36% to $4.3 million in 2025, then soared by 56.84% to $6.8 million in 2026.
- The last three Prepaid Assets figures came in at $6.8 million (Q1 2026), $4.3 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Enanta Pharmaceuticals | 365.48 Mn | 201.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 8.59 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Dec 31, 2024 | 10.68 Mn |
| Sep 30, 2024 | 12.41 Mn |
| Jun 30, 2024 | 15.26 Mn |
| Mar 31, 2024 | 10.93 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 13.26 Mn |
| Jun 30, 2023 | 17.07 Mn |
| Mar 31, 2023 | 14.48 Mn |
| Dec 31, 2022 | 17.95 Mn |
| Sep 30, 2022 | 13.45 Mn |
| Jun 30, 2022 | 11.54 Mn |
| Mar 31, 2022 | 14.08 Mn |
| Dec 31, 2021 | 11.51 Mn |
| Sep 30, 2021 | 14.19 Mn |
| Jun 30, 2021 | 12.14 Mn |